Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China · Delayed Price · Currency is CNY
69.59
+1.65 (2.43%)
Feb 3, 2026, 3:04 PM CST

SHE:300573 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
379.51370.12480.42515.45686.3637.22
Cash & Short-Term Investments
379.51370.12480.42515.45686.3637.22
Cash Growth
-24.60%-22.96%-6.80%-24.90%1744.12%-25.51%
Accounts Receivable
370.07277.93252.1194.96170.62158.23
Other Receivables
2.233.373.934.625.843.15
Receivables
372.3281.3256.03199.58176.46161.37
Inventory
171.88153.6136.03122.2792.3368.31
Other Current Assets
2124.932.7127.8729.2727.32
Total Current Assets
944.69829.92905.19865.17984.42294.22
Property, Plant & Equipment
1,178992.22837.35695.92548.6527.9
Long-Term Investments
1010----
Other Intangible Assets
145.67134.5778.2927.6622.8323.83
Long-Term Deferred Tax Assets
27.7522.538.5723.7730.4533.87
Long-Term Deferred Charges
76.3864.44118.76105.0360.7728.22
Other Long-Term Assets
36.887445.6865.3939.7857.67
Total Assets
2,4192,1282,0241,7831,687965.7
Accounts Payable
23.9817.7317.5719.4613.316.67
Accrued Expenses
78.36178.33125.36103.97108.9191.74
Short-Term Debt
120.06200.1770.06-10080
Current Portion of Leases
8.076.286.877.124.18-
Current Income Taxes Payable
95.5222.845.74-11.69-
Current Unearned Revenue
1.673.466.762.016.115.11
Other Current Liabilities
170.6732.6727.7619.8922.6328.98
Total Current Liabilities
498.33461.48260.12152.45266.83212.49
Long-Term Leases
5.788.862.226.697.1-
Long-Term Unearned Revenue
58.0764.1371.5871.568.4259.15
Total Liabilities
562.18534.48333.92230.63342.35271.64
Common Stock
245.35175.25124.5988.5688.182.37
Additional Paid-In Capital
-866.51891.01852.36782.68288.16
Retained Earnings
803.32551.4674.32611.4479327.11
Treasury Stock
-----5.28-13.26
Comprehensive Income & Other
808.63-----2.2
Total Common Equity
1,8571,5931,6901,5521,344682.19
Minority Interest
-----11.87
Shareholders' Equity
1,8571,5931,6901,5521,344694.06
Total Liabilities & Equity
2,4192,1282,0241,7831,687965.7
Total Debt
133.91215.3179.1513.81111.2880
Net Cash (Debt)
245.6154.81401.27501.64575.08-42.78
Net Cash Growth
-4.07%-61.42%-20.01%-12.77%--
Net Cash Per Share
1.000.631.652.082.56-0.19
Filing Date Shares Outstanding
245.35245.35244.19243241.74226.01
Total Common Shares Outstanding
245.35245.35244.19243241.74226.01
Working Capital
446.37368.44645.07712.72717.5981.72
Book Value Per Share
7.576.496.926.395.563.02
Tangible Book Value
1,7121,4591,6121,5251,322658.36
Tangible Book Value Per Share
6.985.946.606.275.472.91
Buildings
-517.5476.93470.69350.19347.48
Machinery
-759.99711.75534.35481.36438.86
Construction In Progress
-196.85106.1670.1234.9422.31
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.